Radiopharm Theranostics (RADX) Q3 2026 Earnings

28AugConfirmed
Q1 2025
Q3 2025
Q1 2026
Q3 2026
-0.01
-0.01
-0
-0

Details

Expected EPS
-0.00542847613
Actual EPS
-0.00393905226
Surprise EPS
0
Surprise Percent
+27.44%

Description

Radiopharm Theranostics (RADX) has reported earnings of -0.00393905226 per share for Q3 2026.

0 Comments

Share your thoughts